GlassScriptPhysician profile
Karin L Orourke
NPI 1750500757
$4,748.45
in general payments reported to CMS, 2019-2025
18 companies · $975 in 2025
The $975 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $701 · 2022: $854 · 2023: $1,199 · 2024: $1,020 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,193.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $981.35 | 2021-2025 | Lifevest |
| Medtronic, INC. | $880.93 | 2023-2025 | Abre, Spiderfx, In.Pact Admiral |
| Shockwave Medical, INC | $807.63 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $313.55 | 2021-2023 | Farxiga, Brilinta |
| Abbott Laboratories | $313.36 | 2021-2025 | Emboshield Nav6, Femostop, Esprit |
| Scpharmaceuticals INC. | $275.00 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $244.75 | 2022-2025 | Camzyos |
| Pfizer INC. | $189.54 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $169.40 | 2022 | |
| Becton, Dickinson and Company | $144.74 | 2022 | |
| Bridgebio Pharma, INC. | $119.10 | 2025 | Attruby |
| Alexion Pharmaceuticals, INC. | $97.43 | 2022 | |
| Novartis Pharmaceuticals Corporation | $65.93 | 2021-2022 | |
| Boston Scientific Corporation | $60.50 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $26.56 | 2023 | Xarelto |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $23.06 | 2023 | Inpefa |
| Terumo Medical Corporation | $19.01 | 2022 | |
| Ge Healthcare | $16.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karin Orourke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.